Adeno-associated virus vector-mediated transduction in the cat brain

Gene Therapy

Volumn 10, Issue 22, 2003, Pages 1874-1881

  Vite, Charles H ^a,b   Passini, Marco A ^a,b,c   Haskins, Mark E ^a   Wolfe, John H ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

AAV; Animal model; Central nervous system; Feline

Indexed keywords

BETA GLUCURONIDASE; LYSOSOME ENZYME; PARVOVIRUS VECTOR; VIRUS VECTOR;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CAPSULA INTERNA; CAT; CAUDATE NUCLEUS; CONTROLLED STUDY; ENZYME HISTOCHEMISTRY; GENE EXPRESSION; GENETIC TRANSDUCTION; GRAY MATTER; IN SITU HYBRIDIZATION; MAMMAL; NEWBORN; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPORTER GENE; SEROTYPE; THALAMUS; THERMOSTABILITY; WHITE MATTER;

ANIMALS; BRAIN; CATS; DEPENDOVIRUS; GENE EXPRESSION; GENETIC VECTORS; GLUCURONIDASE; HISTOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS; MODELS, ANIMAL; SEROTYPING; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ANIMALIA; DNA VIRUSES; FELIDAE; FELIS CATUS; MAMMALIA; PARVOVIRUS;

EID: 0141996932     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302087     Document Type: Article

References (46)

1. Scriver CR, Beaudet AL, Sly WS, Valle D. Metabolic Bases of Inherited Disease 8th edn. McGraw Hill: NY, 2001, pp, 3369-3894.
2. Sly WS, Vogler C. Brain-directed gene therapy for lysosomal storage disease: going well-beyond the blood-brain barrier. Proc Natl Acad Sci USA 2002; 99: 5760-5762.
3. Skorupa AF et al. Sustained production of β-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999; 160: 17-27.
4. Daly TM et al. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296-2300.
5. Elliger SS et al. Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector. Gene Therapy 1999; 6: 1175-1178.
6. Ghodsi A et al. Systemic hyperosmolality improves β-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp Neurol 1999; 160: 109-116.
7. Bosch A et al. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum Gen Ther 2000; 11: 1139-1150.
8. Passini MA, Wolfe JH. Widespread gene delivery and structure specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J Virol 2001; 75: 12382-12392.
9. Brooks AI et al. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc Natl Acad Sci USA 2002; 99: 6216-6221.
10. Summers BA, Cummings JF, de Lahunta A. Veterinary Neuropathology., Mosby: St Louis, MO, 1995.
11. Jolly RD, Walkley SU. Lysosomal storage diseases of animals: an essay in comparative pathology. Vet Pathol 1997; 34: 527-548.
12. Watson DJ, Wolfe JH. Lentiviral vectors for gene transfer to the central nervous system: applications in lysosomal storage disease animal models. In: Machida C (ed). Viral Vectors for Gene Therapy: Methods and Protocols, Humana Press: Totowa, NJ, 2002 pp 383-403.
13. Berman AL. The Brain Stem Of The Cat, A Cytoarchitectonic Atlas With Stereotaxic Coordinates, University of Wisconsin Press: Madison, 1968.
14. Berman AL, Jones EG. The Thalamus And Basal Telencephalon of the Cat: A Cytoarchitectonic Atlas with Stereotaxic Coordinates, University of Wisconsin Press: Madison, 1982.
15. Rabinowitz JE, Samulski RJ. Building a better vector: the manipulation of AAV virions. Virology 2000; 278: 301-308.
16. Gao G-P et al. Novel adeno-associated viruses for rhesus monkeys as vectors for human gene delivery. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
17. Davidson BL et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions of the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432.
18. Wolfe JH, Deshmane SL, Fraser NW. Herpesvirus vector gene transfer and expression of β-glucuronidase in the central nervous system of MPS VII mice. Nat Genet 1992; 1: 379-384.
19. Casal ML, Wolfe JH. In utero transplantation of fetal liver cells in the mucopolysaccharidosis type VII mouse results in low-level chimerism, but overexpression of beta-glucuronidase can delay onset of clinical signs. Blood 2001; 97: 1625-1634.
20. Fratantoni JC, Hall CW, Neufeld EF. Hurler and Hunter syndromes: mutual correction of the defect in cultures fibroblasts. Science 1968; 162: 570-572.
21. Taylor RM, Wolfe JH. Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase. Nat Med 1997; 3: 771-774.
22. Chirioni JA et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997; 71: 6823-6833.
23. Rutledge EA, Halbert CL, Russell DW Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
24. Bantel-Schaal U, Delius H, Schmidt R, zur Hausen H. Human adeno-associated virus type 5 is only distantly related to other known primate helper-dependent parvoviruses. J Virol 1999; 73: 939-947.
25. Chiorini JA, Kim F, Yang L, Kotin RM. Cloning and characterization of adeno-associated virus type 5. J Virol 1999; 73: 1309-1319.
26. Xiao W et al. Gene therapy based on adeno- associated virus type 1. J Virol 1999; 73: 3994-4003.
27. Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type-2 virions. J Virol 1998; 72: 1438-1445.
28. Duan D et al. Enhancement of muscle delivery with pseudotypes adeno-associated virus type 5 correlates with myoblast differentiation. J Virol. 2001; 75: 7662-7671.
29. Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
30. Walters RW et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001; 276: 20610-20616.
31. Sferra TJ et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis Type VII mouse. Hum Gene Ther 2000; 11: 507-519.
32. Elliger SS, Elliger CA, Lang C, Watson GL. Enhanced secretion and uptake of β-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis Type VII mice. Mol Ther 2002; 5: 617-626.
33. Frisella WA et al. Intracranial. injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis Type VII. Mol Ther 2001; 3: 351-358.
34. Fu H et al. Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene therapy. Mol Ther 2002; 5: 42-49.
35. Alisky JM et al. Tranduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Mol Neurosci 2000; 11: 2669-2673.
36. Kaplitt MG et al . Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148-154.
37. McCown TJ et al. Differential and persistent expression of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99-107.
38. During MJ et al . In vivo expression of therapeutic genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Therapy 1998; 5: 820-827.
39. Peel AL, Klein RL. Adeno-associated virus vectors: activity and applications in the CNS. J Neurosci Methods 2000; 98: 95-104.
40. Shimazaki K et al. Adeno-associated virus vector-mediated bcl-2 gene transfer into post-ischemic gerbil brain in vivo: prospects for gene therapy of ischemic-induced neuronal death. Gene Therapy 2000; 7: 1244-1249.
41. Mastakov MY, Baer K, Kotin RM, During MJ. Recombinant adeno-associated virus serotypes 2-and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion. Mol Ther 2002; 5: 371-380.
42. Passini MA, Lee EB, Heuer GG, Wolfe JH. Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. J Neurosci 2002; 22: 6436-6446.
43. Bartlett JS, Samulski RJ, McCown TJ. Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998; 9: 1181-1186.
44. Hildinger M et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199-6203.
45. Heuer GG et al. Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible. Ann Neurol 2002; 52: 762-770.
46. Barthel LK, Raymond PA. In situ hybridization studies of retinal neurons. Methods Enzymol 2000; 316: 579-590.